Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate for Prevention of AF Post Cardiac Surgery
NCT06675500Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Magnesium Sulfate with Placebo (2 arms). Primary endpoint: Number of Participants With New Episodes of Atrial Fibrillation at 7 days. Started Nov 2024; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06675500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06675500.